Adrenal disease

Pheochromocytoma in von Hippel‐Lindau Disease: Clinical Features and Comparison With Sporadic Pheochromocytoma

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

VHL disease-related PPGLs were often multifocal and noradrenergic, and more likely to relapse compared with sporadic PPGLs. No relationships were identified between the mutation sites and the clinical characteristics of PPGLs.

Study context

Population
Patients with von Hippel-Lindau (VHL) disease and pheochromocytomas and paragangliomas (PPGLs) treated in a single centre, 2007–2023
Participants
59 vs 145
Exposure
VHL disease-related PPGLs vs sporadic PPGLs
  • VHL PPGLsn = 59
  • Sporadic PPGLsn = 145reference
Outcome
Clinical features of VHL-related PPGLs
Methodological detailssingle-centre, Clinical data retrospectively reviewed; VHL mutation testing by Sanger sequencing
  • Single-centre
  • Clinical data retrospectively reviewed; VHL mutation testing by Sanger sequencing

Main finding

As reported in the abstract

VHL disease patients with PPGLs
59 (65.6%) of 90
Age at diagnosis, years
25.0 ± 13.3
Male: female
38:21
Lesions only in adrenal gland
42 (71.2%)
Lesions both in and out of adrenal gland
16 (27.1%)
Multiple lesions
45 (76.3%)
Recurrence after surgery
18 (45.0%)

Observational data: associations, not effects.

Further findings

Adrenal location

P < 0.001

Multiple lesions

P < 0.001

Noradrenaline secretion

P < 0.001

Relapse after surgery

P < 0.001

VHL genetic testing

Underwent testing, all with pathogenic or likely pathogenic VHL mutations
58
Missense mutations
53 (91.4%)
Missense mutations in Elongin-C binding domain
34
Hotspot mutation sites
codon 161 and codon 167
Novel mutations
5
No significant differences in clinical characteristics between mutation-site groups

Original publication

Pheochromocytoma in von Hippel‐Lindau Disease: Clinical Features and Comparison With Sporadic Pheochromocytoma. Clin Endocrinol (Oxf). Published 25 December 2024. doi:10.1111/cen.15190

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.